Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 9, 2009 - Issue 11
Submit an article Journal homepage
230
Views
53
CrossRef citations to date
0
Altmetric
Reviews

Foamy virus vectors for gene transfer

Grant D Trobridge Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N., D1-100, Seattle, WA 98109-1024, USA +1 206 667 6653; +1 206 667 6124; [email protected]
, PhD
Pages 1427-1436 | Published online: 10 Sep 2009

Bibliography

  • Switzer WM, Salemi M, Shanmugam V, Ancient co-speciation of simian foamy viruses and primates. Nature 2005;434(7031):376-80
  • Wick G, Grubeck-Loebenstein B, Trieb K, Human foamy virus antigens in thyroid tissue of Graves' disease patients. Int Arch Allergy Immunol 1992;99(1):153-6
  • Schweizer M, Turek R, Hahn H, Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 1995;11(1):161-70
  • Heneine W, Switzer WM, Sandstrom P, Identification of a human population infected with simian foamy viruses [see comments]. Nat Med 1998;4(4):403-7
  • Switzer WM, Bhullar V, Shanmugam V, Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 2004;78(6):2780-9
  • Linial M. Why aren't foamy viruses pathogenic? Trends Microbiol 2000;8(6):284-9
  • Meiering CD, Linial ML. Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 2001;14(1):165-76
  • Donahue RE, Kessler SW, Bodine D, Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992;176(4):1125-35
  • Murray SM, Picker LJ, Axthelm MK, Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J Virol 2008;82(12):5981-5
  • Murray SM, Linial ML. Foamy virus infection in primates. J Med Primatol 2006;35(4-5):225-35
  • Boneva RS, Switzer WM, Spira TJ, Clinical and virological characterization of persistent human infection with simian foamy viruses. AIDS Res Hum Retroviruses 2007;23(11):1330-7
  • Boneva RS, Grindon AJ, Orton SL, Simian foamy virus infection in a blood donor. Transfusion 2002;42(7):886-91
  • Lochelt M, Zentgraf H, Flugel RM. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology 1991;184(1):43-54
  • Lochelt M, Yu SF, Linial ML, Flugel RM. The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology 1995;206(1):601-10
  • Rethwilm A, Erlwein O, Baunach G, The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci USA 1991;88(3):941-5
  • Venkatesh LK, Theodorakis PA, Chinnadurai G. Distinct cis-acting regions in U3 regulate trans-activation of the human spumaretrovirus long terminal repeat by the viral bel1 gene product. Nucleic Acids Res 1991;19(13):3661-6
  • Trobridge GD, Russell DW. Helper-free foamy virus vectors. Hum Gene Ther 1998;9(17):2517-25
  • Heinkelein M, Schmidt M, Fischer N, Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors. J Virol 1998;72(8):6307-14
  • Lochelt M, Romen F, Bastone P, The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc Natl Acad Sci USA 2005;102(22):7982-7
  • Bock M, Heinkelein M, Lindemann D, Rethwilm A. Cells expressing the human foamy virus (HFV) accessory Bet protein are resistant to productive HFV superinfection. Virology 1998;250(1):194-204
  • Moebes A, Enssle J, Bieniasz PD, Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 1997;71(10):7305-11
  • Yu SF, Baldwin DN, Gwynn SR, Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 1996;271(5255):1579-82
  • Yu SF, Sullivan MD, Linial ML. Evidence that the human foamy virus genome is DNA. J Virol 1999;73(2):1565-72
  • Zack JA, Arrigo SJ, Weitsman SR, HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990;61(2):213-22
  • Enssle J, Jordan I, Mauer B, Rethwilm A. Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc Natl Acad Sci USA 1996;93(9):4137-41
  • Trobridge G, Josephson N, Vassilopoulos G, Improved foamy virus vectors with minimal viral sequences. Mol Ther 2002;6(3):321-8
  • Schmidt M, Rethwilm A. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 1995;210(1):167-78
  • Nestler U, Heinkelein M, Lucke M, Foamy virus vectors for suicide gene therapy. Gene Ther 1997;4(11):1270-7
  • Heinkelein M, Dressler M, Jarmy G, Improved primate foamy virus vectors and packaging constructs. J Virol 2002;76(8):3774-83
  • Wu M, Chari S, Yanchis T, Mergia A. cis-Acting sequences required for simian foamy virus type 1 vectors. J Virol 1998;72(4):3451-4
  • Park J, Nadeau PE, Mergia A. A minimal genome simian foamy virus type 1 vector system with efficient gene transfer. Virology 2002;302(2):236-44
  • Bastone P, Bravo IG, Lochelt M. Feline foamy virus-mediated marker gene transfer: identification of essential genetic elements and influence of truncated and chimeric proteins. Virology 2006;348(1):190-9
  • Bastone P, Romen F, Liu W, Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors. Gene Ther 2007;14(7):613-20
  • Achong BG, Mansell PW, Epstein MA, Clifford P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 1971;46(2):299-307
  • Herchenroder O, Renne R, Loncar D, Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 1994;201(2):187-99
  • Schweizer M, Neumann-Haefelin D. Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 1995;207(2):577-82
  • Zucali JR, Ciccarone T, Kelley V, Transduction of umbilical cord blood CD34+ NOD/SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector. Virology 2002;302(2):229-35
  • Russell DW, Miller AD. Foamy virus vectors. Journal of virology 1996;70(1):217-22
  • Hirata RK, Miller AD, Andrews RG, Russell DW. Transduction of hematopoietic cells by foamy virus vectors. Blood 1996;88(9):3654-61
  • Peters K, Barg N, Gartner K, Rethwilm A. Complex effects of foamy virus central purine-rich regions on viral replication. Virology 2008;373(1):51-60
  • Wiktorowicz T, Peters K, Armbruster N, Generation of an improved foamy virus vector by dissection of cis-acting sequences. J Gen Virol 2009;90(Pt 2):481-7
  • Bastone P, Lochelt M. Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors. Gene Ther 2004;11(5):465-73
  • Schenk T, Enssle J, Fischer N, Rethwilm A. Replication of a foamy virus mutant with a constitutively active U3 promoter and deleted accessory genes. J Gen Virol 1999;80(Pt 7):1591-8
  • Trobridge GD, Allen JM, Peterson L, Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency. Hum Gene Ther 2009;20:519-23
  • Kiem HP, Allen J, Trobridge G, Foamy virus-mediated gene transfer to canine repopulating cells. Blood 2007;109(1):65-70
  • Patton GS, Erlwein O, McClure MO. Cell-cycle dependence of foamy virus vectors. J Gen Virol 2004;85(Pt 10):2925-30
  • Duda A, Luftenegger D, Pietschmann T, Lindemann D. Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain. J Virol 2006;80(16):8158-67
  • Hill CL, Bieniasz PD, McClure MO. Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol 1999;80(Pt 8):2003-9
  • Pietschmann T, Heinkelein M, Heldmann M, Foamy virus capsids require the cognate envelope protein for particle export. J Virol 1999;73(4):2613-21
  • Baldwin DN, Linial ML. The roles of Pol and Env in the assembly pathway of human foamy virus [see comments]. J Virol 1998;72(5):3658-65
  • Fischer N, Heinkelein M, Lindemann D, Foamy virus particle formation. J Virol 1998;72(2):1610-5
  • Vassilopoulos G, Trobridge G, Josephson NC, Russell DW. Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. Blood 2001;98(3):604-9
  • Takeuchi Y, Liong SH, Bieniasz PD, Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation. J Virol 1997;71(8):6174-8
  • Lindemann D, Bock M, Schweizer M, Rethwilm A. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol 1997;71(6):4815-20
  • Sun Z, Zeng Y, Li Y, Lentiviral FANCA vectors pseudotyped with a modified foamy viral envelope corrects murine Fanca-/- hematopoietic stem cells with reduced toxicity and higher efficiency [abstract]. Mol Ther 2009;17(Supplement1):S292
  • Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 2008;26:317-53
  • Baumann JG. Intracellular restriction factors in mammalian cells: an ancient defense system finds a modern foe. Curr HIV Res 2006;4(2):141-68
  • de Vries W, Haasnoot J, van der Velden J, Increased virus replication in mammalian cells by blocking intracellular innate defense responses. Gene Ther 2008;15(7):545-52
  • Mangeat B, Trono D. Lentiviral vectors and antiretroviral intrinsic immunity. Hum Gene Ther 2005;16(8):913-20
  • Brown BD, Sitia G, Annoni A, In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 2007;109(7):2797-805
  • Perkovic M, Schmidt S, Marino D, Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J Biol Chem 2009;284(9):5819-26
  • Munk C, Beck T, Zielonka J, Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol 2008;9(3):R48
  • Russell RA, Wiegand HL, Moore MD, Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol 2005;79(14):8724-31
  • Gartner K, Wiktorowicz T, Park J, Accuracy estimation of foamy virus genome copying. Retrovirology 2009;6:32
  • Yap MW, Lindemann D, Stanke N, Restriction of foamy viruses by primate Trim5alpha. J Virol 2008;82(11):5429-39
  • Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001;14(4):778-809, table of contents
  • Rhodes-Feuillette A, Saal F, Lasneret J, Studies on in vitro interferon induction capacity and interferon sensitivity of simian foamy viruses. Arch Virol 1987;97(1-2):77-84
  • Sabile A, Rhodes-Feuillette A, Jaoui FZ, In vitro studies on interferon-inducing capacity and sensitivity to IFN of human foamy virus. Res Virol 1996;147(1):29-37
  • Tan J, Qiao W, Wang J, IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus. J Virol 2008;82(9):4275-83
  • Santoni de Sio FR, Gritti A, Cascio P, Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. Stem Cells 2008;26(8):2142-52
  • Santoni de Sio FR, Cascio P, Zingale A, Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction. Blood 2006;107(11):4257-65
  • Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990;10(8):4239-42
  • Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994;68(1):510-6
  • Naldini L, Blomer U, Gallay P, In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272(5259):263-7
  • Trobridge G, Russell DW. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol 2004;78(5):2327-35
  • Park F, Ohashi K, Chiu W, Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 2000;24(1):49-52
  • Yamashita M, Emerman M. Retroviral infection of non-dividing cells: old and new perspectives. Virology 2006;344(1):88-93
  • Bieniasz PD, Weiss RA, McClure MO. Cell cycle dependence of foamy retrovirus infection. J Virol 1995;69(11):7295-9
  • Lehmann-Che J, Renault N, Giron ML, Centrosomal latency of incoming foamy viruses in resting cells. PLoS Pathog 2007;3(5):e74
  • Caprariello AV, Miller RH, Selkirk SM. Foamy virus as a gene transfer vector to the central nervous system. Gene Ther 2009;16(3):448-52
  • Varmus HE, Weiss RA, Friis RR, Detection of avian tumor virus-specific nucleotide sequences in avian cell DNAs (reassociation kinetics-RNA tumor viruses-gas antigen-Rous sarcoma virus, chick cells). Proc Natl Acad Sci USA 1972;69(1):20-4
  • Nienhuis AW, Dunbar CE, Sorrentino BP. Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 2006;13(6):1031-49
  • Josephson NC, Vassilopoulos G, Trobridge GD, Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc Natl Acad Sci USA 2002;99(12):8295-300
  • Neves M, Peries J, Saib A. Study of human foamy virus proviral integration in chronically infected murine cells. Res Virol 1998;149(6):393-401
  • Trobridge GD, Miller DG, Jacobs MA, Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci USA 2006;103(5):1498-503
  • Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003;300(5626):1749-51
  • Schroder AR, Shinn P, Chen H, HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002;110(4):521-9
  • Nowrouzi A, Dittrich M, Klanke C, Genome-wide mapping of foamy virus vector integrations into a human cell line. J Gen Virol 2006;87(Pt 5):1339-47
  • Hendrie PC, Huo Y, Stolitenko RB, Russell DW. A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses. Mol Ther 2008;16(3):534-40
  • Park J, Nadeau P, Zucali JR, Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs. Virology 2005;343(2):275-82
  • Taylor JA, Vojtech L, Bahner I, Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication. Mol Ther 2008;16(1):46-51
  • Gharwan H, Hirata RK, Wang P, Transduction of human embryonic stem cells by foamy virus vectors. Mol Ther 2007;15(10):1827-33
  • Rothenaigner I, Kramer S, Meggendorfer M, Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression. Gene Ther 2009;16(3):349-58
  • Josephson NC, Trobridge G, Russell DW. Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors. Hum Gene Ther 2004;15(1):87-92
  • Leurs C, Jansen M, Pollok KE, Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34(+) cord blood cells. Hum Gene Ther 2003;14(6):509-19
  • Horn PA, Keyser KA, Peterson LJ, Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. Blood 2004;103(10):3710-6
  • Beard BC, Keyser KA, Trobridge GD, Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus. Hum Gene Ther 2007;18(5):423-34
  • Bauer TR Jr, Allen JM, Hai M, Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 2008;14(1):93-7
  • Si Y, Pulliam AC, Linka Y, Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells. Blood 2008;112(12):4458-65
  • Liu W, Liu Z, Liu L, A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury. Neurosci Lett 2008;432(1):13-8
  • Wei BL, Denton PW, O'Neill E, Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. J Virol 2005;79(9):5705-12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.